Biomarker Commercialization – IVD applicable Biomarker Research and Innovation implementation Development GuidE


April 2021 -
December 2021

Uncompleted
1. Innovation 1.3 Non-tech innovation

BiC BRIDGE

Small and medium sized enterprises in the medical sector are currently hampered in bringing new biomarkers to the market. Both the EU Regulation on in vitro diagnostics of 2017 and established requirements towards industrial processes are challenging to them. BiC BRIDGE helps smaller players of the biomarker development sector to streamline their biomarker development, and provides guidance, both on the regulatory framework and on the necessary steps linked to commercialisation.

BiC BRIDGE builds on the tools developed in the BIC project.

Project Stories

Budgets

Total
€ 0.76
million
Erdf
€ 0.58
million
Eni + Russia
€ 0.00
million
Norway
€ 0.00
million

PARTNERS

Social Media

Twitter